Instem Announces Acquisition of RockStep Solutions, Inc.
The acquisition of RockStep enables Instem to now provide an integrated solution of both Provantis ®, Instem's market-leading solution for GLP preclinical study management, and Climb. The combined solution will offer best-in-class GLP study management design with the flexibility to support non-GLP studies and will be the most comprehensive and advanced software for any type of facility engaged in preclinical research. This fusion of products and technologies expands the Instem solution suite to manage breeding, handling, moving, or genotyping animals, subject census management, study design, PK/PD analysis, pathology management, necropsy, study data visualization features, and more.
'At Instem, our mission is to help our customers make discoveries, and to accelerate and advance their research programs. The acquisition of RockStep and integration of Climb into our Provantis platform strengthens this commitment, enabling a fully connected, end-to-end environment that spans from early discovery through non-GLP and GLP study management to regulatory submission. By unifying these workflows under one provider, we help reduce risk, eliminate inefficiencies, and drive greater scientific and operational impact across the preclinical R&D lifecycle.' Vik Krishnan, CEO, Instem.
The acquisition of RockStep adds many new large and industry-leading customers in the pharmaceutical and CRO spaces.
Instem and RockStep together form the most experienced and talented team dedicated to the management and analysis of preclinical research data. The solution suite is significantly expanded to assemble a complete enterprise system for preclinical study management, tracking all aspects of breeding, census, veterinary procedures, study design and execution, including PK/PD analysis, along with data visualization and analytics. Climb offers a technologically advanced, flexible platform for non-GLP study designs and facilitates vivarium management, including animal health tracking and real-time alerts. This combined solution suite unifies teams and acts as a data hub, allowing scientists and lab staff to collaborate and communicate from anywhere. Large Pharma, Biotech, and CROs need flexibility and the ability to operate across different workstreams, studies, research types, and disease areas, which Instem is now able to offer through the combination of Provantis and Climb.
About Instem
Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Founded in the United Kingdom in 1969, Instem has deep roots internationally across North America, EMEA and APAC. Instem maintains a commercial and technical presence throughout these regions, and we pride ourselves on localized support for our diverse client base.
Learn more about Instem here: www.instem.com
About RockStep Solutions, Inc.
RockStep Solutions was founded in 2013 by Chuck Donnelly, a software engineer with experience working for life sciences companies, and Julie Morrison, a microbiology scientist. Since these early beginnings, RockStep has maintained a strong commitment to innovation, today partnering with Microsoft to integrate advanced technologies in the Azure cloud into our industry-leading Climb™ software. Launched in 2017, Climb has been adopted by a wide range of life sciences innovators – from global pharmaceutical companies and CROs to biotech organizations, government labs, a Nobel Laureate's lab at UCSF, and research labs at The Jackson Laboratory.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
HIMS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 23, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ('Hims & Hers' or the 'Company') (NYSE:HIMS) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Hims securities between April 29, 2025 and June 23, 2025, both dates inclusive (the 'Class Period'). Investors have until August 25, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose to investors: (1) that Hims was engaged in the 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;' (2) that, as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Additionally, the Complaint alleges that Defendants made false and/or misleading statements, as well as failed to disclose material facts, including that: (1) the communication between Hims and the pharmaceutical company Novo Nordisk A/S ('Novo') would facilitate a long-term collaboration that would ensure continued access to the weight-loss drug Wegovy for Hims subscribers; (2) Novo approved of Hims' offerings of compounded semaglutide products under the 'personalization' exception; (3) branded Wegovy would be offered alongside compounded semaglutide options on the Hims platform, thereby expanding user choice; and (4) Defendants made positive statements abou the Novo partnership and Hims users' ongoing access to Wegovy alongside compounded semaglutide products. If you purchased or otherwise acquired Hims & Hers shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, Walker, Passmore, Esq.(212) 355-4648 [email protected]
Yahoo
4 hours ago
- Yahoo
UnitedHealth Group Announces Changes to Leadership Team
July 31, 2025--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced Wayne S. DeVeydt has been appointed its chief financial officer, effective September 2, 2025. John F. Rex, who joined the company in 2012 and has been CFO since 2016, will become strategic advisor to the CEO on the same date. "Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to health care that is a perfect fit for UnitedHealth Group," said Stephen J. Hemsley, company chairman and chief executive officer. "John Rex has been an exceptional leader, having helped guide our company through substantial change with both strategic vision and strong commitment to our mission," said Hemsley. "I look forward to his continued insights as UnitedHealth Group moves forward." DeVeydt, 55, most recently has been a managing director and operating partner at Bain Capital, working with client leaders on operational improvement and growth acceleration. From 2018-2020, he was chairman and CEO of Surgery Partners, Inc. in Nashville, expanding the operational scale and financial performance of the surgical services firm. He joined Anthem, Inc. (now Elevance) in 2005 and served as its chief financial officer from 2007 to 2016. Prior to joining Anthem, DeVeydt served as a partner with PricewaterhouseCoopers LLP, with a focus on the health care sector. "There is no organization besides UnitedHealth Group that presents the kinds of opportunities to make a difference in health care, from individual patient care to broad system efficiency, so I am eagerly looking forward to joining the team," said DeVeydt. "I've been fortunate to know John Rex for over two decades and am honored to follow a leader of his caliber." Rex, 63, joined UnitedHealth Group as chief financial officer of the company's then newly established Optum business and previously had spent his career focused in health care across multiple roles and sectors. "This pivotal moment for UnitedHealth Group is the right time for a new yet greatly experienced executive like Wayne DeVeydt, and I look forward to supporting him and the entire leadership team while continuing to advise on a range of matters," said Rex. About UnitedHealth Group UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at and follow UnitedHealth Group on LinkedIn. View source version on Contacts Media: uhgmedia@ UnitedHealth Group Media Sign in to access your portfolio
Tom's Guide
13 hours ago
- Tom's Guide
We canceled our $4,000 pool service after trying this powerful robot pool cleaner
Our house came with a pool. While my three kids were ecstatic about this, I immediately felt overwhelmed at the thought of maintenance. My husband always had a pool growing up, but his parents usually took care of the labor. Because we knew nothing that first year with the pool, I hired a pool service to take care of the pool; from opening and closing to everything in between, I didn't have to do anything. While it was nice, the pool service was incredibly expensive. I knew there had to be a better way. Enter the Beatbot AquaSense 2 Ultra. This year, we opened the pool late, and in my rush, I yanked the cover off solo. Without my husband's help, I winced as sticks, pinecones and soggy leaves tumbled into the water. It was a mess. Thankfully, I had just received the Beatbot AquaSense 2 Ultra, the company's most advanced cordless robot. With our pool service on hold for another week, I figured this was the perfect moment to see what it could really do. We replaced our pricey pool service with the Beatbot AquaSense 2 Ultra. It cleaned better, ran longer and made maintenance totally hands-free. We have a backyard filled with trees and the robot easily picked up the numerous leaves in the pool. It was then we knew that this robot was a keeper, and after just two weeks with the AquaSense 2 Ultra, we canceled our service entirely (a savings of over $4,000!). With cordless AI pathfinding, surface parking and five-in-one cleaning, from the floor to floating debris, this sleek little robot quickly became our go-to for pool maintenance. It quietly handled the mess nature made. The AquaSense 2 Ultra handled nearly every aspect of maintenance, from floor cleaning to surface skimming to waterline scrubbing. It even uses an eco-friendly clarifying agent made from recycled crab shells to keep water crystal clear. Our pool looked professionally cleaned, and I didn't lift a finger (well, except to open the app). Easy set-up: The box was so big and the packaging was so overwhelming that I put off the set up. However, once I finally opened it, I was pleasantly surprised by just how quick it was to set up the app and get the machine running. Truly hands-free cleaning: The AquaSense 2 Ultra cleans floors, walls, the waterline and even the surface, all while filtering and clarifying the water with its built-in ClearWater™ system. It's basically five devices in one. Smart navigation + obstacle detectionEquipped with 27 onboard sensors and a HybridSense™ AI system, the robot maps your pool, avoids obstacles and adapts its path in real-time. Even with a bunch of my kids' diving toys scattered around, it powered through efficiently with minimal overlap or missed spots. User-friendly recovery: When complete or running on a low battery, it floats to the edge. This was a total game-changer because we our old vacuum, I always had to literally get in the pool to retrieve the robot if it wasn't near the side. Long runtime: With up to 10 hours of surface cleaning and 5 hours of deep cleaning on a single charge, the Ultra can tackle even large or debris-heavy pools. Works in above ground pool, too: I wasn't sure if the Ultra would work in an above ground pool and planned on reviewing it just for an in-ground pool, but it worked beautifully in an above ground pool, too! Our neighbors with a huge above-ground pool, were impressed when I let them use the bot. Water clarification built-in: One unexpected perk was how the water looked noticeably clearer. I'm talking sparkling. That's thanks to the robot's ability to circulate and clarify using a safe, biodegradable agent, something no vacuum we've used before could do. App control and voice alerts: The app lets you control direction, view cleaning routes, and schedule cleanings. And real-time voice updates tell you when the cleaning is done or the battery is low, great when I'm not poolside. App connectivity issues: Bluetooth and Wi‑Fi control can be flaky underwater. I lost connection several times and the inability to operate features like Park Mode once submerged was tricky. We are on an acre of land and the pool is way in the backyard, so that could be part of the issue. It's on the heavy side: Although I go to the gym and consider myself pretty strong, I can barely lift this machine. I have to ask my husband to take it out of the pool and walk it to the charger in the garage. Any time I do it myself, I have to use a hand truck. The Beatbot AquaSense 2 Ultra is best suited for pool owners who want near-total automation with minimal effort. It's an ideal choice for families with large, debris-heavy, or uniquely shaped pools, and for anyone tired of dealing with tangled cords, manual skimming or constant upkeep. If you're looking for crystal-clear water without the daily hassle, the Ultra delivers. For those who've dreamed of a truly hands-free pool maintenance routine, this robot absolutely lives up to the hype. Our pool has never looked better, and that includes the times when we had professionals servicing it weekly. The Beatbot AquaSense 2 Ultra has replaced nearly every step of maintenance with quiet, reliable automation. It's become one of those devices I now can't imagine summer without. When I empty the filter basket, I'm still amazed at what it captures: leaves, bugs, sunscreen residue, pine needles, all gone, with zero manual skimming. It is so satisfying. If you're serious about pool care but tired of recurring costs or daily upkeep, this robot is a game-changer. Yes, the upfront investment is steep, but when I compare it to a full season of service fees, the Ultra pays for itself fast. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button.
